GATA3 and carcinoma: This subgroup of tumors presents much lower positivity for typical breast markers, such as mammaglobin (17–24% positivity), GCDFP-15 (0–5%), and GATA3, which show a lower expression than that identified in luminal carcinomas or HER2 [48].